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Abstract.  Chinese hamster ovary cell mutants resist- 
ant to the microtubule stabilizing drug taxol were iso- 
lated in a single step. Of these  139 drug-resistant mu- 
tants, 59 exhibit an absolute requirement for taxol for 
normal growth and division,  13 have a partial require- 
ment, and 69 grow normally without the drug. Two- 
dimensional gel analysis of whole cell proteins reveal 
"extra" spots representing altered tubulins in  13 of the 
mutants. Six of these have an altered a-tubulin and 
seven have an altered ~-tubulin. Cells with an absolute 
dependence on taxol become large and multinucleated 
when deprived of the drug. In contrast, partially de- 
pendent cells exhibit some multinucleation, but most 
cells appear normal. In one mutant that has an abso- 
lute dependence on taxol, the cells appear to die more 
quickly and their nuclei do not increase in size or 
number. 
As previously found for another taxol-dependent 
mutant (Cabral, F.,  1983, J. Cell. Biol., 97:22-29), the 
taxol dependence of the mutants described in this pa- 
per behaves recessively in somatic cell hybrids, and 
the cells are more susceptible to being killed by col- 
cemid than are the wild-type parental cells. When 
compared with wild-type cells, taxol-dependent mu- 
tants have normal arrays of cytoplasmic microtubules 
but form much smaller mitotic spindles in the pres- 
ence of taxol. When deprived of the drug, however, 
these mutants cannot complete assembly of the mi- 
totic spindle apparatus, as judged by tubulin immuno- 
fluorescence. Thus, the defects leading to taxol de- 
pendence in these mutants with defined alterations in 
,- and ~-tubulin appear to result from the cell's ina- 
bility to form a functional mitotic spindle. Reversion 
analysis indicates that the properties of at least one a- 
tubulin mutant are conferred by the altered tubulin 
seen on two-dimensional gels. 
M 
ICROTUBULES are involved in many important cel- 
lular functions including mitosis, particle and or- 
ganelle transport by saltatory motion, and secretion 
( 11, 25). Much has been learned about microtubule assembly 
and  function through the use of morphological techniques 
and specific microtubule-inhibiting drugs. Our understanding 
of microtubule assembly and organization has also been fur- 
thered by in vitro polymerization studies and by the ability to 
visualize arrays of these structures in whole cells with fluores- 
cently labeled antibodies. Another approach that has been 
enormously successful  in studying biological processes is the 
combination of genetics and biochemistry. This type of ap- 
proach has only recently been used to study the cytoskeleton 
and should provide much useful information about the con- 
trol of microtubule assembly and function, especially when 
combined with the morphological techniques available. 
Early attempts were made to select yeast and Chlamydo- 
monas cells resistant to microtubule-inhibiting drugs (1,  15, 
29).  The specific  defects responsible for the drug resistance 
phenotype, however, could not be demonstrated. Later inves- 
tigations with  the  fungus Aspergillus  proved more  useful. 
Mutants resistant to benomyl were found to have alterations 
in ~-tubulin, and a revertant of one of  these strains was found 
to have an altered a-tubulin (18,  26).  Using these mutants, 
the authors were able to demonstrate that nuclear movement 
in that organism is microtubule dependent (19, 20). In mam- 
malian  cells,  Ling and Thompson first  isolated colchicine- 
resistant mutants in Chinese hamster ovary (CHO) cells ~  (16). 
Although these mutants had defects in membrane permeabil- 
ity, later mutants isolated by the same group were shown to 
have altered colcemid binding affinity, and one had an alter- 
ation in c~-tubulin (14,  17). In our laboratory we have em- 
ployed a  similar  approach,  i.e.,  selecting cells  resistant  to 
microtubule-active drugs to obtain CHO mutants with dis- 
tinct alterations in a- and fl-tubulin (4, 6, 7, 9, 21, 22). 
Most microtubule inhibitors cause microtubules to break 
down, but one, taxol, stabilizes  microtubules and promotes 
their assembly (23, 24). Among CHO cells resistant to taxol, 
a mutant was discovered that required the continuous pres- 
ence of the drug for cell division and long term viability (3, 
10). This mutant  has  no  altered forms of c~- or ~-tubulin 
detectable by two-dimensional gel analysis.  The biochemical 
lesion responsible for the phenotype of this mutant is still 
unknown. 
We now report the isolation of many new taxol-requiring 
CHO cell lines, some of which carry altered forms of a- and 
Abbreviations used in this paper." CHO, Chinese hamster ovary; HAT, hypo- 
xanthine-aminopterin-thymidine. 
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acterizations of some of these strains. 
Materials and Methods 
Sources of  Drugs and Antibodies 
Taxol (NSC) ( 125973-N1 lot FB 1021-58-61 ) was kindly supplied by the Devel- 
opmental Therapeutics Branch of the National Cancer Institute. Colcemid was 
obtained  from Gibco  (Grand Island, NY).  Puromycin,  ouabain,  and amino- 
pterin  were obtained  from Sigma Chemical  Co.  (St. Louis,  MO). Affinity- 
purified  anti-tubulin  antibodies  were the  kind  gift of Dr.  Bill R.  Brinkley 
(University of Alabama, Birmingham, AL). 
Mutant Isolation 
The CHO cell line used in these studies and the conditions for its growth have 
been previously described (27). To isolate mutants, ceils were plated onto 100- 
ram tissue culture  dishes (5  ×  106  cells/dish)  containing  i0  mt  minimum 
essential medium (alpha-modification,  Flow Laboratories inc..  McLean, VA) 
supplemented  with  10%  fetal bovine  serum (MA  Bioproducts,  Walkersville, 
MD),  2 mM glutamine,  50  U/ml of penicillin,  and  50  ug/ml streptomycin 
(Flow Laboratories  Inc.). The dishes were then incubated  at 37"C for  1 h to 
allow cells to attach.  The cells were rinsed twice with Dulbecco's  phosphate- 
buffered saline (PBS) and covered with 5 ml  more of PBS. They  were then 
irradiated for 13 s at a distance of 24 in with a 15-W General Electric germicidal 
lamp. The mutagenized cells were allowed to recover and grow in flasks for 3 
d before being plated onto selective medium.  The surviving fraction of muta- 
genized cells was ~20%. 
Taxol-resistant cells were selected by plating 5 ×  105 mutagenized cells onto 
each of 14  100-mm dishes with 20 ml complete  medium and 0.3 ug/ml taxol 
(diluted from a stock solution containing  I mg/ml in dimethyl sulfoxide). After 
7 d at 37"C, 139 of the surviving clones were isolated and grown in medium 
containing 02 ug/ml taxol. In all further procedures, cells grown in the presence 
of taxol were grown in medium containing 0.2 ~g/ml of the drug except where 
indicated otherwise. The clones were then subjected to three different screening 
procedures.  Cells were tested  for their  ability to grow in complete  medium 
without taxol to determine  if they were taxol dependent. They were also grown 
in medium containing  7 ug/ml of puromycin to look for cross-resistance to 
this drug, thereby  allowing us to detect  putative  permeability  mutants (2, 9, 
22). Finally, whole cell lysates of each clone were analyzed by two-dimensional 
gel  electrophoresis  to  identify  those  that  contain  tubulin  with  an  altered 
electrophoretic mobility. 
Other Procedures 
Two-dimensonal gel analysis (5), growth measurements, viability measurements 
and  phase  microscopy  (3), and  antitubulin  immunofluoreseence  (10)  were 
performed as described earlier. Somatic cell hybridizations were performed by 
fusing mutant cells with a wild-type strain (10512) which contains markers for 
8-azaguanine  (hypoxanthine-aminopterin-thymidine  [HAT]  sensitivity)  and 
ouabain  resistance as described earlier (13). Approximately  106 cells of each 
mutant strain (and also the wild-type parent) were plated onto a 60-ram dish 
with an equal number of cells from strain  10512 and allowed to attach.  Cells 
were fused with  polyethylene  glycol 1000, incubated  overnight  in  medium, 
trypsinized, resuspended in 22 ml medium,  and aliquoted into dishes (0.5 ml 
into  each  of four dishes, 5 ml into each  of another four dishes) containing 
various amounts of taxol. The cells were again incubated  overnight, and the 
medium was then replaced with HAT/ouabain medium containing  the same 
amount of taxol. The cells were incubated for 7 d and stained with methylene 
blue, and colonies were counted.  Before cells were stained, a few colonies were 
picked and grown in HAT/ouabain medium with taxol for karyotyping. 
For selection of revertants,  cultures  of mutant cells growing in taxol-con- 
taining medium were trypsinized, plated onto 100-ram dishes at a density of 5 
×  105 cells in medium without taxol, and incubated for 1 wk. Several growing 
colonies were picked and grown in fresh medium, then subcloned. 
Results 
Taxol-dependent Clones Are Found at High 
Frequency Among Cells Selected for Resistance to 
Taxol; Permeability Mutants Are Rare 
Taxol-resistant clones were found at a frequency of 2.5 ×  10  -4 
among cells mutagenized with ultraviolet light. The results of 
our selection are  summarized in  Fig.  1.  From  13  different 
dishes,  139 taxol-resistant clones were isolated and grown in 
taxol containing medium. They were then screened for taxol 
dependence  by  plating  in  taxol-free  medium.  Of the  139 
clones,  57  exhibited an absolute requirement for taxol; i.e., 
all cells ceased dividing and became large and multinucleated 
within 2 d of growth without taxol. Also,  13 additional clones 
had a partial requirement for the drug. These cells could grow 
and form colonies in the absence of taxol, albeit much more 
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Figure 1.  Results of selection of ultraviolet-irradiated CHO cells for 
resistance to 0.3 ug/ml of taxol. Mutants were tested for drug resist- 
ance and requirement as described in Results. 
Figure 2.  Autoradiograms of the tubulin region of two-dimensional 
gels of [35S]methionine-labeled whole cell  proteins of laxol-requiring 
CHO cell  mutants. Cells were labeled for 30 min in [35S]methionine, 
lysed in SDS, and analyzed by two-dimensional gel electrophoresis as 
previously described (9). (a) Wild-type pattern; (b)/3-tubulin mutant 
Tax  11-3; (c) c~-tubulin  mutant Tax  1 I-6; (d) a-tubulin mutant Tax 
2-3. In a, cq and c~2 are spots representing a-tubulin;/3,/3-tubulin; V, 
vimentin; A, actin. In b-d, arrows indicate spots representing altered 
forms of tubulin proteins. Note that c~-tubulin  resolves as two spots 
on  our  gels.  These  do  not  represent  distinct  gene  products  but 
probably result from a posttranslational modification. 
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multinucleated cells could be found among these clones after 
2 d of growth in the absence of the drug. 
Cells were also screened for resistance to puromycin, a drug 
that inhibits protein synthesis and has no specific effects on 
microtubules. This procedure identifies cells with membrane 
permeability defects that  have been found to occur at high 
frequency among cells selected for resistance to microtubule 
inhibitors.  Such cells are cross-resistant to a  wide variety of 
drugs and are thus unlikely to have specific defects in micro- 
tubules (2, 9, 22). Among the 139 taxol-resistant clones, only 
10 were resistant to puromycin at a level that kills wild-type 
cells (7 #g/ml). It is not surprising that none of  the puromycin- 
resistant clones required taxol for normal growth. 
Mutants Containing Altered a- and ~-Tubulins Are 
Found among Both Taxol-resistant  and 
-dependent  Clones 
For initial screening, whole cell lysates of the 139 clones were 
prepared  in  hot  SDS  sample buffer and  analyzed  by two- 
dimensional gel electrophoresis (5) followed by silver staining 
(31).  Clones carrying altered forms of a- or #-tubulin  were 
recloned  in  soft agar,  grown,  pulsed  with  [35S]methionine, 
lysed in SDS buffer, and run again on two-dimensional gels. 
Among the 139 taxol-resistant clones, six were found to have 
two  "new"  spots  representing  mutant  a-tubulin  migrating 
next to the two wild-type a-tubulin spots; seven have a new 
spot representing mutant B-tubulin next to wild-type/~-tubu- 
lin.  The  presence  of these  "new"  spots  is  consistent  with 
results previously reported  from this laboratory (9,  22)  for 
CHO mutants with altered tubulins. 
Of the  13 clones that exhibit tubulin with an altered elec- 
trophoretic  mobility,  seven  (three  a,  four  /~)  were  found 
among the 59 taxol-resistant but non-requiring clones and six 
(three a, three ~) were among the 70 taxol-dependent mutants 
(Fig.  1). Representative autoradiograms of the tubulin regions 
from  two-dimensional  gels  of some  of these  mutants  are 
shown in Fig. 2. Altogether four distinct patterns among the 
six mutants with an altered a-tubulin and two distinct patterns 
among the seven mutants with an altered #-tubulin have been 
identified.  As  expected,  none  of  the  puromycin-resistant 
clones carried an altered tubulin. 
Some Tubulin Mutants Require Taxol 
for Cell Division 
Two taxol-dependent  clones,  one  containing  an  altered  a- 
tubulin (Tax l 1-6) and the other carrying an altered #-tubulin 
(Tax 11-3), were chosen for further characterization. For some 
studies,  other  clones  were  also  used.  Growth  of these  two 
clones and of wild-type cells  was measured in the presence 
and  absence  of taxol.  Wild-type  cells  grew  rapidly  with  a 
doubling time of 12  h  in  the  absence of taxol,  but  ceased 
growing and dividing after 24 h  in the presence of the drug 
(Fig.  3a).  Tax  l 1-6, which  contains  an  altered  ~-tubulin, 
showed a nearly opposite growth pattern from the wild-type 
cells. These cells grew with a doubling time of ~14 h  in the 
presence of taxol. When deprived of the drug, however, they 
stopped growing after 24 h  (Fig.  3b).  Tax  I 1-3, a  #-tubulin 
mutant,  also grew  well  with  taxol  present  but  was growth 
inhibited in the absence of the drug (not shown). Another a- 
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Figure 3. Growth curves of wild-type cells and taxol-requiring tubulin mutants in the absence of taxol (©) and the presence of 0.3 #g/ml of 
taxol (O).  Cells were trypsinized from replicate wells of a 24-well dish at various times and counted as described previously (3).  The vertical 
axis represents the number of cells in a given well after incubation at 37"C for a given period. (a) Wild-type cells; (b) fully dependent mutant 
Tax  11-6: (c) partially dependent mutant Tax 2-3. 
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As shown in Fig. 3 c, this mutant grew with a doubling time 
of ~ 13 h in the presence of taxol,  but in the absence of the 
drug, the doubling time was increased to ~37 h. Growth of 
this mutant was never completely inhibited in the absence of 
the drug, unlike growth of the other mutants. 
The effect of taxol deprivation on the growth of the fully 
taxol-dependent  mutants  is  irreversible  and  similar  to  the 
effect on the original  taxol requiring mutant, Tax 18 (3). We 
measured the loss of cell viability  using a method described 
earlier (3), i.e., by measuring the plating efficiency of the cells 
after various periods of taxol deprivation. Fig. 4 shows that 
Tax 11-3 and 11-6, like the previously described mutant Tax 
18, lose the ability to form plainly visible macroscopic colo- 
nies when taxol is removed from the medium for more than 
a  few hours. Cells  of Tax  11-3 are  more sensitive  to taxol 
deprivation than are those of Tax 11-6. 
Taxol-dependent Mutants Deprived of Taxol 
Assume Altered Morphologies 
In all strains examined, mutants that are completely depend- 
ent upon taxol begin to exhibit gross morphological changes 
after 24 h of growth in the absence of the drug. Fig. 5a is a 
phase-contrast micrograph of wild-type cells growing without 
taxol in  the medium.  Fig.  5 b shows  the/~-tubulin  mutant, 
Tax 2-4, growing in the presence of taxol;  these cells appear 
similar to those shown in  Fig.  5 a.  Of our taxol-dependent 
mutants, Tax 2-4 is the most sensitive  to taxol deprivation. 
After 24  h  without  the  drug,  some cells  became multinu- 
cleated,  but most stopped dividing altogether and began to 
die (Fig. 5 c). This effect became even more pronounced after 
48 h without the drug (Fig. 5 d).  A more typical situation is 
found  with  Tax  11-6, which  resembles  the  previously de- 
scribed mutant Tax 18 when deprived of taxol (3). After 24 h 
without the drug, most of the cells became large and multi- 
nucleated  (Fig.  5 e).  Mitotic cells appeared larger  and con- 
tained more chromosomes than those grown in the presence 
of the drug. After 48 h without the drug, interphase cells were 
even larger and contained more micronuclei (Fig. 5f). Mitotic 
cells were  also  larger  than those deprived of taxol for 24 h 
and  had  many chromosomes. We also examined the  mor- 
phologies of our partially dependent mutants after taxol dep- 
rivation.  Fig.  5g shows  cells of Tax 2-3  after 24 h without 
taxol.  Some cells became multinucleated, but most retained 
their normal morphology. After 48 h without taxol,  the af- 
fected cells were even larger and contained many nuclei,  but 
most cells still appeared normal. 
Taxol Dependence in Somatic Cell 
Hybrids Is Recessive 
To test whether the taxol-dependent phenotype is dominant 
or recessive, cell hybrids were constructed between wild-type 
parental cells and the mutant strains as described in Materials 
and Methods. As shown in Table I, all of the hybridizations 
produced large  numbers of colonies when plated on HAT/ 
ouabain medium without taxol. This result would be expected 
if the  taxol  dependence  phenotype were  recessive.  A  few 
hybrids of mutant and wild-type cells grew at the intermediate 
(0.05 and 0.1 /zg/ml) concentrations of taxol,  but very few of 
the wild-type/wild-type hybrids grew at these concentrations. 
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Figure  4.  Viability of taxo] requiring tubulin mutants Tax 11-3 (a) 
and Tax  11-6 (b)  after  the  removal  of taxol.  Approximately 500 
mutant cells were plated onto replicate 60-ram dishes and exposed to 
taxol-free  medium for various periods before taxo] was added back. 
Colonies were allowed to form (7-10 d at 37°C) and then counted. 
The fraction surviving is the number of colonies able to form on a 
dish deprived of taxol for a  given period, divided by the number of 
colonies able to  form  on  a  dish in  which cells were kept  in  taxol- 
containing medium throughout the experiment. 
This result indicates that the phenotype for taxol resistance is 
weakly co-dominant. 
Taxol-dependent Cells Have Increased Resistance to 
Taxol but Increased Sensitivity to Colcemid 
Our taxol-requiring CHO strains  were selected for resistance 
to taxol at a concentration of 0.3  ug/ml. To determine the 
levels of resistance  to, and dependence on, taxol,  ~ 100 cells 
of each  strain  to be  tested  were  added  to wells of 24-well 
Schibler and Cabral  Taxol-requiring CHO Tubulin Mutants  1525 Figure 5. Phase-contrast micrographs of taxol-requiring mutants cultured in the continuous presence of taxol or deprived of taxol for 24 or 48 
hours. Cells were photographed on a Nikon Diaphot microscope with a 40x objective lens. (a) Wild-type parental cells grown without taxol; 
(b-d) fully requiring mutant Tax 2-4 growing in medium containing 0.2 ug/ml of taxol (b) or deprived of taxol for 24 (c) or 48 (d) h. (e and 
f) Fully requiring mutant Tax  11-6 after growth without taxol for 24 (e) or 48 (f) h. (g and h) Partially requiring mutant Tax 2-3 after growth 
without taxol for 24 (g) or 48 (h) h. Note that almost all cells in b have normal morphologies although one or two are multinucleated. In c, 
note the increase in number of multinucleated cells and altered morphologies of some cells (arrows).  In d,  note the necrotic appearance of 
several  cells  (arrow).  In  e  and f,  most  interphase and  mitotic  cells  (arrows)  are  larger  and  are  either multinucleated  or  contain  many 
chromosomes. In g and h, only some cells suffer the effects of taxol deprivation (arrows), whereas most appear normal. Bar, 2 um. Table I. Fusions of Wild-type Cells with Taxol-requiring 
Mutants 
Strain fused with wild type 
WT  Tax 2-4  Tax  11-3  Tax 11-6 
Fraction of fused  0.9  0.1  0.9  0.1  0.9  0.1  0.9  0.1 
cells 
Concentration of 
taxol (ug/ml) 
0  175  107  510  145  729  142  380  76 
0.05  2  0  440  31  80  5  181  4 
0.1  0  0  40  6  7  1  3  1 
0.2  0  0  0  0  0  0  0  0 
5 x  10  ~ cells of wild4ype or a taxol-requiring  strain  were mixed on a culture 
dish with 5 x  l0  ~  cells of a wild-type containing HAT  s and Ouabain rt markers. 
Cells were fused with polyethylene glycol, plated in HAT medium containing 
ouabain,  and given concentrations of taxol.  Plates were incubated for 7 d and 
stained with methylene blue, and colonies were counted. 
taxol.  One mutant, 2-4, does not grow well even at 0.05 ug/ 
ml taxol and thus appears to have a more severe defect than 
the other strains.  Similar  patterns of taxol resistance  or de- 
pendence are  seen  for cells with  alterations  in  a-  or in  fl- 
tubulin. Note that a colcemid-resistant line previously isolated 
(9)  is  more  sensitive  to  taxol  than  is  the  wild  type.  An 
explanation for this observation will be provided in the dis- 
cussion. 
In a  similar experiment,  the  mutants were  tested  for in- 
creased  resistance  or sensitivity  to colcemid, a microtubule- 
disrupting drug. Because taxol and colcemid have antagonistic 
actions and because  several of our mutants require taxol for 
growth,  we had to include taxol in these experiments.  Fig. 7 
shows the effects of colcemid and taxol on the growth of the 
wild-type parent cell line, the fully taxol-dependent fl-tubulin 
mutant Tax  11-3, and the colcemid-resistant fl-tubulin  mu- 
tant Cmd 4.  Without taxol in  the medium, wild-type  cells 
grow in colcemid at concentrations of up to 0.01  ttg/ml. In 
the  presence  of 0.05  #g/ml  taxol,  the  cells  can  grow  in 
colcemid at up to 0.02/~g/ml. The addition of taxol beyond 
Figure 6. Growth of taxol-resistant and -requiring mutants in taxol. 
Approximately 100 cells were added to wells containing medium with 
varying concentrations of taxol, grown for 7-8 d at 37"C, and stained 
with methylene blue. Taxol concentrations are given as micrograms 
taxol per milliliter medium.  WT, wild-type parental cells; Cmd 4, a 
colcemid resistant/~-tubulin mutant; Tax 2-4, a fully taxol-requiring 
~-tubulin mutant;  11-3, another fully taxol-requiring B-tubulin mu- 
tant;  11-6, a  fully taxol-requiring a-tubulin  mutant;  2-3, a  partially 
taxol-requiring c~-tubulin mutant;  5-6, a  taxol-resistant (non-requir- 
ing) a-tubulin mutant;  1-19, a  taxol-resistant (non-requiring) fl-tub- 
ulin mutant. 
dishes containing medium with various concentrations of the 
drug. As shown in Fig. 6, the taxol-resistant  mutants are from 
two- to fourfold more resistant  to the drug than are wild-type 
cells.  Some  strains,  such  as  2-4,  11-3,  and  11-6,  which  we 
define as having an absolute requirement for taxol, exhibit no 
growth in the absence of the drug, whereas strains 2-3 and 2- 
5, which we have designated as partially requiring mutants, 
exhibit only limited growth and form small colonies without 
Figure 7. Growth of cells in various concentrations of colcemid and 
taxol. Plates were prepared and treated as described in legend to Fig. 
6  except that colcemid and taxol were added in the concentrations 
shown.  Colcemid  concentrations  in  micrograms  per  milliliter  in- 
creased  from  left  to  right  and  taxol  in  micrograms  per  milliliter 
increased from top to bottom for each strain. WT, wild-type parental 
cells; Tax  11-3, a  fully taxol-dependent fl-tubulin mutant; Cmd 4, a 
colcemid-resistant fl-tubulin mutant. 
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and,  in  fact,  inhibits  the  growth  of the  wild-type cells.  As 
expected,  mutant  11-3  did  not grow without  taxol,  but  its 
colcemid sensitivity could be measured as long as taxol was 
present in the growth medium. This cell line did not survive 
beyond 0.005 ~g/ml colcemid regardless of how much taxol 
was added to the medium. Thus, mutant  11-3 is hypersensi- 
tive to colcemid as compared with wild-type cells.  The addi- 
tion of taxol to Cmd 4, a colcemid-resistant mutant, did not 
significantly alter its colcemid resistance but rather inhibited 
the  growth  of those  cells  at  all  concentrations  tested.  This 
result  reinforces the  data  presented  in  Fig.  6  and  indicates 
that the two drugs do not balance each other's effects in this 
cell line. 
Because  all  of the  taxol-resistant  and  -requiring  mutants 
grew  well  in  a  concentration  of 0.1  ~g/mi  of taxol,  this 
concentration of the drug was included in all further experi- 
ments designed to test the colcemid sensitivity of  the mutants. 
As indicated in Fig. 8, these mutants are all hypersensitive to 
colcemid  except  for Tax  1-19.  The  results  did  not  change 
when the concentration of taxol was varied in the experiment 
(data  not shown).  The  lack of colcemid hypersensitivity in 
Tax  1-19  is as yet unexplained but could indicate that this 
strain falls into a different class from the other taxol-resistant 
tubulin mutants we have isolated. 
Taxol-dependent  Tubulin Mutants Cannot Form a 
Functional Mitotic Spindle in the Absence of  the Drug 
As  with  the  previously  described  mutant,  Tax  18  (3),  the 
mutants  described  in  this  paper  require  the  presence  of a 
microtubule-stabilizing agent for normal division and growth. 
To observe the disposition of microtubule arrays within the 
cells  after  taxol  deprivation  and  also  to  determine  if the 
tubulin alterations in these mutants affect their ability to form 
functional mitotic spindles,  as was observed in mutant  Tax 
18 (10), mutant cells were grown with and without taxol and 
subjected to indirect immunofluorescence using antitubulin 
antibodies.  When  mutants  11-3  and  11-6  (as well  as  other 
Figure 8. Growth of  taxol-dependent and -resistant mutants in various 
concentrations  of colcemid. Wells of 24-well dishes were prepared as 
described in legend to Fig. 6 except that the concentrations  of col- 
cemid in micrograms per milliliter shown at the top plus 0.1 #g/ml 
of taxol were added to each well. See text for details and legend to 
Fig. 6 for descriptions of mutant cell lines. 
strains  we  have  examined)  were  grown  in  the  presence  of 
taxol, the cells exhibited a  normal cytoplasmic microtubule 
network  similar  in  appearance  to  those  of wild-type  cells 
grown in the absence of taxol (data not shown). After 24 and 
48  h  of taxol deprivation,  mutant cells were larger but  still 
contained large arrays of microtubules as previously reported 
for Tax 18 (10). Thus, the taxol dependence in these tubulin 
mutants probably does not result from an inability of  the cells 
to form cytoplasmic microtubules. 
When mitotic cells were examined,  spindles of the taxol- 
dependent cells grown in the presence of the drug (Fig. 9a) 
appeared to be smaller than those of wild-type cells (Fig. 9 c). 
The polar areas of these cells fluoresced brightly, and bundles 
of microtubules (presumably kinetochore bundles) extended 
to the equatorial plane. Typical organization of  chromosomes 
on the metaphase plate was confirmed using differential  in- 
terference contrast microscopy (Fig. 9, b and d).  Many ana- 
phase and telophase cells and midbodies could also be seen 
in these preparations,  indicating that these cells could com- 
plete mitosis. In mitotic cells of the mutants deprived of taxol 
for 24 h, a few spindles like the latter were observed, but most 
of the mitotic cells contained abnormal looking spindles with 
disorganized metaphase chromosomes (Fig. 9, e and f). After 
48 h without the drug, mitotic cells were larger and contained 
more spindle poles and more disorganized chromosomes (Fig. 
9,  g  and  h).  That  no  metaphase  or  anaphase  spindles  or 
midbodies could be found among cells grown in the absence 
of taxol indicates a lack of cell division. 
Reversion of  Mutant Tax 11-6 to Taxol Independence 
Is Associated  with the Loss of the Altered a-Tubulin 
on Two-Dimensional  Gels 
Three  of the  mutant  cell  lines  2-4,  11-3,  and  11-6  were 
subcloned,  and  spontaneous  taxol-independent  revertants 
were selected. The spontaneous reversion frequency of Tax 2- 
4  (<3  x  10  -s) was much lower than those of the other two 
mutants (8.1  x  10-5 for 11-3  and 3.7  x  10  -4 for 11-6), thus 
making isolation of revertants very difficult. However, several 
taxol-independent revertants of Tax  11-3 and Tax  11-6 have 
been isolated. Cells from 48 Tax  l 1-3 revertants and  18 Tax 
11-6  revertants  were grown, pulse-labeled with  [35S]methio- 
nine,  and  analyzed by two-dimensional gel  electrophoresis. 
Based on this analysis, two types of taxol independent fever- 
rants of Tax  11-6  but only one type of Tax  11-3  revertant 
could  be  distinguished.  16  of the  Tax  11-6  revertants  still 
retained the altered a-tubulin  spots on the gels.  Two of the 
revertants, however, no longer contained the spots represent- 
ing the altered a-tubulin. The co-segregation of taxol depend- 
ence and the altered tubulin at high frequency strongly sug- 
gests that  the  taxol-dependent  phenotype  in  Tax  11-6  is  a 
result of the alteration  in a-tubulin.  All of the 48 revertants 
of Tax  11-3,  however, retained  the altered B-tubulin.  Thus, 
we  cannot yet unambiguously ascribe  taxol  dependence  in 
these cells to an alteration in/3-tubulin, even though such an 
association is likely. 
Discussion 
A mutant of CHO ceils that requires the presence of taxol, a 
microtubule-stabilizing drug, for normal growth and cell di- 
vision was recently described by this laboratory (3,  10). When 
The Journal of  Cell Biology.  Volume 102, 1986  1528 Figure 9. Antitubulin  immunofluorescence  and differential interference contrast  (DIC) microscopy of CHO cells in mitosis. Cells grown on 
coverslips were fixed and stained for immunofluorescence  as described in Materials and Methods. (a and b) Wild-type metaphase spindle; (c 
and d) metaphase spindle of Tax  11-6 grown in 0.2 pg/ml taxol. Note the small size of the spindle as compared with the wild type. (e and f) 
Bipolar cell of Tax 11-6 grown without taxol for 24 h. Note the concentration  of fluorescence at the poles. (g and h) multipolar cell of Tax 11- 
6 grown without taxol for 48 h. Immunofluorescence  is shown in a, c, e, g, the corresponding DIC images in b, d,f, h. Bars, 5 tLm. 
the  mutant  is  deprived of the drug, the cells become larger 
and multinucleated and eventually die. Further studies indi- 
cated that the defect in the mutant cells affects their ability to 
form a functional mitotic spindle. Although the physiological 
consequences of the mutation in these cells have been char- 
acterized,  the biochemical lesion responsible for the pheno- 
type has not yet been determined. 
We now report the  isolation  of many new taxol-resistant 
cell lines that are also taxol dependent. Of 139 taxol-resistant 
clones,  70 have a  partial  or complete requirement  for taxol 
for normal growth and cell division. The physiological con- 
sequences of the lesions in the new taxol-dependent mutants 
are, for the most part, similar to those found in the previously 
described mutant,  Tax  18 (3).  The isolation and analysis of 
this  new set  of taxol-dependent  mutants,  however,  has fur- 
thered our understanding oftaxol dependence in several ways. 
First,  in ~ 10%  of the drug-dependent mutants,  dependence 
correlates with and probably results from an alteration  in a 
tubulin  protein.  Furthermore,  reversion analysis of one mu- 
tant with an altered a-tubulin strongly suggests that mutations 
in  a-tubulin  can lead to taxol dependence,  mutations in/~- 
tubulin  probably  do  as  well.  Finally,  we  have  found  that 
different mutants have varying sensitivities to taxol depriva- 
tion. 
Only l 0 of the taxol-resistant clones were cross-resistant to 
puromycin at  a  level that  kills  wild-type cells;  none of the 
taxol-dependent clones was also puromycin resistant.  Thus, 
in  our  selection,  taxol-dependent  clones  were  found  at  a 
frequency of 50%, and putative permeability mutants com- 
prised  <10%  of the drug-resistant  clones.  The selection  for 
resistance to taxol, a microtubule-stabilizing agent, therefore, 
contrasts significantly with selections for resistance to micro- 
tubule-disrupting  drugs (such as  colcemid,  vinblastine,  and 
maytansine;  see  references  9  and  22)  in  that  selections  for 
resistance to the latter drugs results primarily in the isolation 
of permeability mutants with cross-resistance to puromycin. 
Almost 10% of  all the mutants isolated (13/139) and nearly 
9%  of the  taxol-dependent  subclass  (6/70)  contain  altered 
forms of a- or ~3-tubulin  detectable  by two-dimensional gel 
analysis. The actual frequency of tubulin mutants among the 
taxol-resistant  and  -dependent  mutants  is  probably  higher 
because  only  those  mutants  that  show  an  alteration  in  a 
tubulin protein in their two-dimensional gel patterns (i.e.,  in 
their isoelectric points) were identified.  On a  random basis, 
only one third of missense mutations cause a  change in the 
isoelectric point of a resultant protein (28). Alterations in a- 
and 13-tubulin were common among taxol-resistant cells,  sug- 
gesting that such alterations may lead to resistance or depend- 
ence on taxol.  The isolation of spontaneous revertants  11-6 
that are no longer taxol dependent and have a wild-type two- 
dimensional gel pattern confirms this suggestion. 
The extent to which taxol dependent mutants require the 
drug  appears  to  vary.  In  general,  taxol-dependent  tubulin 
mutants behave like Tax 18, the mutant characterized earlier 
(3,  10).  However,  some clones have  more or less stringent 
requirements  for  taxol.  In  our  initial  screening  for  taxol 
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to form viable colonies in the absence of taxol,  do so at  a 
much  slower  rate  than  taxol-independent  clones.  Further- 
more, many aberrant cells,  similar to those seen in mutants 
more stringently dependent on taxol, can be observed among 
these partially dependent cells when they are deprived of the 
drug. Growth curves show this distinction between partially 
and completely dependent  cells even better.  Without taxol, 
completely  drug-dependent  cells  cease  dividing  altogether 
after 24 h (Fig. 3b). Partially dependent clones can still grow 
after  removal  of taxol  from  the  medium,  but  the  average 
doubling time becomes much greater (Fig. 3 c). 
All five new taxol-dependent mutants that we have exam- 
ined by indirect immunofluorescence with antibodies against 
tubulin  appear to be affected in  their ability to assemble  a 
functional mitotic spindle.  In all of the mutants, there were 
large networks of  cytoplasmic microtubules during interphase, 
even  in  those  which  had  become quite  large  after  2  d  of 
growth without  taxol.  Mitotic  cells  in  cultures deprived  of 
taxol had only very short spindle microtubules concentrated 
in  the  polar regions.  In large  mitotic cells,  several  of these 
polar microtubule remnants could be seen. Thus, in all mu- 
tants so far examined, the defect leading to taxol dependence 
results from an inability of the cell to polymerize properly its 
spindle microtubules into a functional spindle unless the drug 
is present. 
When mutants were observed by phase microscopy after t 
or 2 d of taxol deprivation, most mutants assumed morphol- 
ogies similar to those of Tax  18 cells deprived of the drug. 
Cells became progressively larger and were found to contain 
many micronuclei. Many of these cells appeared to die after 
4-5 d of taxol deprivation. In one taxol-dependent ¢~-tubulin 
mutant, Tax 2-4, the effect was even more drastic. After 24 h 
without the drug, many cells had died, and the culture became 
increasingly  necrotic  the  longer  the  cells  were  deprived  of 
taxol. This mutant appears to have a more stringent require- 
ment for the drug than most taxol-dependent isolates. 
To explain  these observations, taxol dependence in these 
mutants may be thought of in terms of a simple model which 
we have recently presented (7, 22).  In brief,  if one imagines 
that microtubules in the cell must be maintained in a tightly 
regulated  equilibrium  between  the  polymerized  (microtu- 
bules) and  unpolymerized (a# heterodimers)  states,  then  in 
the  presence  of a  microtubule  destabilizing  drug (e.g.,  col- 
cemid or vinblastine) this equilibrium will be shifted toward 
the unpolymerized state to such a degree that the cell will be 
unable to carry out microtubule-mediated events (e.g.,  mito- 
sis).  Conversely,  a  microtubule-stabilizing  drug  (taxol)  will 
prevent  the  cell  from  depolymerizing  its  microtubules  or 
reassembling them in an ordered array for functions such as 
mitosis. We can then think of a colcemid-resistant mutant as 
a cell line with an altered a- or ¢~-tubulin that confers increased 
stability upon the microtubules. Because these microtubules 
are more stable, a higher concentration of colcemid would be 
needed  for symptomatic depolymerization to occur. At the 
same time, however, less taxol would be needed to produce 
hyperstability of these microtubules and the consequent cell 
dysfunctions. Conversely, a taxol-resistant mutant would have 
less stable microtubules. Thus, a higher concentration oftaxol 
would be required to produce microtubule hyperstability, but 
lower concentrations ofcolcemid would produce microtubule 
disruption.  A taxol-dependent mutant may then be thought 
of as an extreme case of a taxol-resistant cell, i.e., the genetic 
lesion has caused the microtubules to become so unstable that 
spindle microtubule assembly cannot occur in the absence of 
an  exogenous stabilizing drug,  taxol.  This  mechanism  also 
predicts the existence of colcemid-dependent mutants, but to 
date only one has been isolated through gene transfer experi- 
ments  using a  strain that was already colcemid resistant as 
the source  of the donor DNA (8).  It is  not surprising  that 
colcemid-dependent  mutants  are  more  difficult  to  obtain, 
since  a  mutation  to  hyperstability  of microtubules  would 
require  stronger  subunit-subunit  interactions  than  have  al- 
ready evolved in the wild-type strain.  A  mutation that pro- 
duces  hyperlabile  microtubules  as  seen  in  taxol-dependent 
mutants,  on  the  other  hand,  would  result  in  less  perfect 
subunit-subunit  interactions.  Such  mutations  should  occur 
much more frequently. 
Although  few  data  are  available  from  other  systems  to 
support this model, Warr et al.  (30) have reported isolating 
CHO mutants with similar patterns of cross-resistance. Also, 
the  properties  of some  tubulin  mutants  of Aspergillus are 
explained very well by it (12, 20). Ben A33, for example, is a 
temperature-sensitive  (ts)  #-tubulin  mutant  of Aspergillus 
(20). At the restrictive temperature these cells fail to exhibit 
nuclear movement or division even though they have appar- 
ently normal spindle  microtubules by immunofluorescence 
(12).  Interestingly, the ts phenotype can be suppressed by a 
variety of microtubule inhibitors or by tub A 1, a mutation in 
a-tubulin (20). These results may be explained by postulating 
that  the  ben  A33  mutation  confers  hyperstability  on  the 
microtubules and that it is the inability of the microtubules 
to depolymerize appropriately that leads to the mitotic defect. 
The addition of exogenous depolymerizing drugs or a muta- 
tion in a-tubulin resulting in hyperlabile microtubules could 
then compensate for the hyperstability introduced by the ben 
A33  mutation,  leading  to  a  microtubule  population  with 
approximately  normal  stability  and  function.  Thus,  these 
experimental observations can be easily interpreted based on 
the model we have presented to explain our own data. 
The morphologies of our mutants  after taxol deprivation 
resemble those of  wild-type cells after exposure to microtubule 
destabilizing drugs. In the latter, cells also become large and 
syncytial. When considered in terms of our model, it can be 
seen that the states of the microtubules in both situations are 
essentially the same (i.e.,  shifted towards depolymerization), 
but one is the result of a genetic lesion and the other is drug 
induced. We may think of the present set of taxol-dependent 
tubulin  mutants as all having highly unstable  microtubules. 
However, since there are varying degrees of taxol dependence 
(Tax 2-3, 2-5 <  Tax  18, Tax  11-3,  t 1-6 <  Tax 2-4), there is 
probably a continuous spectrum of microtubule stability dic- 
tated by the strength of subunit-subunit interactions between 
tubulin subunits or between tubulin and microtubule-associ- 
ated  proteins.  Mutations  that  affect these  interactions  can 
thus produce varying degrees of microtubule instability de- 
pending on the severity of the disruption of subunit-subunit 
interactions. 
Mutations in tubulin genes may account for taxol depend- 
ence  of several  of our  mutants,  but  in  most  of our  new 
mutants,  as in Tax  18, the biochemical lesion remains  un- 
known.  Taxol-dependent  cells cannot be  permeability  mu- 
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are similar  among these different  mutants, microtubules are 
probably the  affected  sites  even  in  those  mutants  with  no 
alteration  in the electrophoretic mobility of tubulins.  If alter- 
ations in the tubulin genes were the only ones responsible for 
the taxol-dependent phenotype, we would expect to be able 
to detect alterations  in isoelectric  points of tubulins in ~30% 
of our  mutants  on  a  random  basis.  However,  only  10% 
contain detectable  tubulin alterations  as compared with 30- 
50%  among  colcemid-  and  maytansine-resistant  mutants. 
Because  microtubules are probably the affected  structures in 
these mutants,  a possible explanation is that  the phenotype 
may result  from  alterations  in  microtubule-associated  pro- 
teins. We are currently screening the taxol-dependent mutants 
for such alterations. 
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